Medirom Healthcare Technologies shares rise 2.02% intraday as MOTHER Labs subsidiary secures 9 billion yen funding for upgraded wearable device development.

Thursday, Oct 9, 2025 11:37 am ET1min read
MRM--
Medirom Healthcare Technologies Inc. surged 2.02% intraday as its subsidiary MOTHER Labs announced approval for an internal financing round valued at 9 billion yen to develop an upgraded MOTHER Bracelet wearable device and its commercialization system. The company primarily operates in health services, including relaxation salons, digital preventive health, and luxury beauty, and drives health tech innovation and business expansion through its subsidiaries.

Medirom Healthcare Technologies shares rise 2.02% intraday as MOTHER Labs subsidiary secures 9 billion yen funding for upgraded wearable device development.

Stay ahead of the market.

Get curated U.S. market news, insights and key dates delivered to your inbox.

Comments



Add a public comment...
No comments

No comments yet